Literature DB >> 56408

Genetic control of the immune response to nuclease. II. Detection of idiotypic determinants by the inhibition of antibody-mediated nuclease inactivation.

C G Fathman, D H Sachs.   

Abstract

The humoral response of mice to staphylococcal nuclease has previously been shown to be controlled genetically by H-2-linked Ir gene(s). In order to examine the possible contributions of variable region immunoglobulin genes to this genetic control, we have developed a system for the detection of idiotypic determinants on anti-nuclease immunoglobulin molecules. Antisera to nuclease were raised in two high responder strains, A/J and SJL. The corresponding antibodies were purified by affinity chromotography on Sepharose-nuclease columns, and were used to immunize groups of Lewis rats. An assay system was developed to assess the inhibition of antibody-mediated inactivation of nuclease activity by the rat antisera thus produced. Despite the presence of many species-specific anti-mouse immunoglobulin antibodies in these sera, inhibition of antibody-mediated enzyme inactivation was found to be specific for anti-nuclease antibodies of the immunizing strain. The inhibition could not be removed by extensive absorption with normal serum proteins from the antibody-producing strain, and was shown to require antibodies directed toward binding sites of the anti-nuclease antibodies. This inhibition thus defines idiotypic determinants of anti-nuclease antibodies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Genetic control of immune response to staphylococcal nuclease. XII: Analysis of nuclease antigenic determinants using anti-nuclease monoclonal antibodies.

Authors:  C A Devaux; P I Nadler; G G Miller; D H Sachs
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

2.  Inhibition of the catalytic properties of Staphylococcus aureus nuclease by monoclonal antibodies.

Authors:  C A Devaux; D G Covell; J Barbet; M el Gamil; D H Sachs
Journal:  Mol Cell Biochem       Date:  1987-04       Impact factor: 3.396

3.  The genetic control of the immune response to staphylococcal nuclease VI. Recombination between genes determining the A/J anti-nuclease idiotypes and the heavy chain allotype locus.

Authors:  D S Pisetsky; D H Sachs
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

4.  Genetic control of the immune response to staphylococcal nuclease. X. Isoelectric focusing spectrotypes of antinuclease antibodies detected by labeling with antigen and with anti-idiotype.

Authors:  G P Miller; D H Sachs
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Genetic control of the immune response to nuclease. V. Genetic linkage and strain distribution of anti-nuclease idiotypes.

Authors:  C G Fathman; D S Pisetsky; D H Sachs
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

6.  Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response.

Authors:  D S Pisetsky; J A Berzofsky; D H Sachs
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

7.  Genetic control of the immune response to staphylococcal nuclease. VIII. Mapping of genes for antibodies to different antigenic regions of nuclease.

Authors:  D S Pisetsky; D H Sachs
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

8.  Genetic control of the immune response to staphylococcal nuclease. IV. H-2-linked control of the relative proportions of antibodies produced to different determinants of native nuclease.

Authors:  J A Berzofsky; A N Schechter; G M Shearer; D H Sachs
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

9.  Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype.

Authors:  G G Miller; P I Nadler; Y Asano; R J Hodes; D H Sachs
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.